Medgend Icon


Tretinoin FDA Approved Drugs

ABSORICA [IsotretinoinC20H28O2]
RX
-
10mg (oral capsule)
20mg (oral capsule)
25mg (oral capsule)
30mg (oral capsule)
35mg (oral capsule)
40mg (oral capsule)
RanbaxyMay 25, 2012
  • Treatment of a skin disorder.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

AMNESTEEM [IsotretinoinC20H28O2]
RX
-
10mg (oral capsule)
20mg (oral capsule)
40mg (oral capsule)
Mylan Pharms IncNov 8, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ATRALIN [TretinoinC20H28O2]
RX
-
0.05% (topical gel)
Dow PharmJul 26, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

AVITA [TretinoinC20H28O2]
RX
-
0.025% (topical gel)
MylanJan 29, 1998
Mylan Pharms IncJan 14, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CLARAVIS [IsotretinoinC20H28O2]
RX
-
10mg (oral capsule)
20mg (oral capsule)
30mg (oral capsule)
40mg (oral capsule)
Teva Pharms UsaApr 11, 2003
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CLINDAMYCIN PHOSPHATE AND TRETINOIN [Clindamycin PhosphateC18H34ClN2O8PS : TretinoinC20H28O2]
RX
-
1.2% : 0.025% (topical gel)
Actavis Mid AtlanticJun 12, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MYORISAN [IsotretinoinC20H28O2]
RX
-
10mg (oral capsule)
20mg (oral capsule)
30mg (oral capsule)
40mg (oral capsule)
Douglas PharmsJan 19, 2012
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PANRETIN [AlitretinoinC20H28O2]
RX
-
eq 0.1% base (topical gel)
Eisai IncFeb 2, 1999
  • Topical treatment of cutaneous lesions in patients with aids-related kaposi's sarcoma.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RENOVA [TretinoinC20H28O2]
RX
-
0.02% (topical cream)
0.05% (topical cream)
Valeant Pharms NorthAug 31, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RETIN-A [TretinoinC20H28O2]
RX
-
0.01% (topical gel)
0.025% (topical cream)
0.05% (topical cream)
0.1% (topical cream)
Valeant IntlApproved Prior To Jan 1, 1982
Valeant BermudaSep 16, 1988
Valeant Pharms NorthApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RETIN-A MICRO [TretinoinC20H28O2]
RX
-
0.04% (topical gel)
0.1% (topical gel)
Valeant IntlMay 10, 2002
  • Treatment of acne vulgaris.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RETIN-A-MICRO [TretinoinC20H28O2]
RX
-
0.08% (topical gel)
Valeant IntlJan 28, 2014
  • Treatment of acne vulgaris.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TRETINOIN [TretinoinC20H28O2]
RX
-
0.01% (topical gel)
0.025% (topical cream)
0.04% (topical gel)
0.05% (topical gel)
0.1% (topical gel)
10mg (oral capsule)
Perrigo Pharma IntlJun 11, 2002
Mylan Pharms IncJul 17, 2013
Zo Skin HealthSep 15, 2005
Anchen PharmsOct 24, 2012
Barr Labs IncJun 22, 2007
Glenmark Pharms LtdDec 23, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TRI-LUMA [Fluocinolone AcetonideC24H30F2O6 : HydroquinoneC6H6O2 : TretinoinC20H28O2]
RX
-
0.01% : 4% : 0.05% (topical cream)
Galderma Labs LpJan 18, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VELTIN [Clindamycin PhosphateC18H34ClN2O8PS : TretinoinC20H28O2]
RX
-
1.2% : 0.025% (topical gel)
Aqua Pharms LlcJul 16, 2010
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZENATANE [IsotretinoinC20H28O2]
RX
-
10mg (oral capsule)
20mg (oral capsule)
30mg (oral capsule)
40mg (oral capsule)
Dr Reddys Labs LtdMar 25, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZIANA [Clindamycin PhosphateC18H34ClN2O8PS : TretinoinC20H28O2]
RX
-
1.2% : 0.025% (topical gel)
MedicisNov 7, 2006
  • Topical treatment of acne vulgaris in patients 12 years or older.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.